62 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Rank Status Study
21 Unknown  Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Hypovitaminosis D;   Hypomagnesemia;   Hyperparathyroidism
Intervention:
22 Unknown  Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Conditions: Chronic Kidney Disease;   Renal Osteodystrophy;   Left Ventricular Hypertrophy
Intervention:
23 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
24 Not yet recruiting A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Drug: EnteraBio's Oral Parathyroid Hormone (1-34)
25 Unknown  Genetic Modifiers for 22q11.2 Syndrome
Condition: 22q11.2 Deletion Syndrome
Intervention: Other: Observation
26 Unknown  FGF-23 Regulation in Chronic Kidney Disease
Condition: Secondary Hyperparathyroidism
Interventions: Drug: Sevelamer Carbonate;   Other: Placebo
27 Recruiting A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Conditions: End-Stage Renal Disease;   Secondary Hyperparathyroidism
Intervention: Drug: paricalcitol
28 Recruiting Renal Osteodystrophy: A Fresh Approach
Condition: Renal Osteodystrophy
Intervention:
29 Unknown  Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma
Condition: Hyperparathyroidism
Intervention: Procedure: C11-Choline PET/CT
30 Recruiting A Prospective Open-Label, Non-randomised, Single-arm, Pilot Clinical Study Evaluating the Effect of PTH Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
Conditions: Moderate to Severe Secondary Hyperparathyroidism;   Stage 5 Chronic Kidney Diseases
Intervention: Drug: Paricalcitol
31 Unknown  Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy
Conditions: Hypocalcemia;   Hypoparathyroidism;   Vitamin D Deficiency;   Thyroidectomy
Intervention:
32 Recruiting The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
Condition: Hyperparathyroidism
Interventions: Drug: captopril;   Drug: Lisinopril
33 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
34 Recruiting To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
35 Recruiting A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary Hyperparathyroidism
Interventions: Drug: ASP7991;   Drug: Cinacalcet;   Drug: Placebo
36 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
37 Unknown  Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism (PHPT)
Intervention:
38 Recruiting Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Hyperparathyroidism, Secondary;   Secondary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
39 Recruiting The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: calcium sensing receptor agonist
40 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years